Revvity Inc vs Upstart Holdings Inc — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while Upstart Holdings Inc trades at $24.1 (market cap $2.35B). The key difference: Revvity Inc is far larger — about 7.2× Upstart Holdings Inc's market cap, and Revvity Inc pays a 0.18% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Upstart Holdings Inc for 39 Days on average.
| RVTY | UPST | |
|---|---|---|
Market Cap | $16.98B | $2.35B |
Volume | 1,456,900 | 4,203,337 |
Sector | Health | Financials |
52-Week High | $157.36 | $52.74 |
52-Week Low | $82.26 | $22.81 |
Typical Hold Time | 12 Days | 39 Days |
Enterprise Value | $19.30B | $3.88B |
Dividend Yield | 0.18% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Upstart Holdings trades at $24.19, up 0.71% with bearish technical signals despite recent partnership expansions. The company achieved profitability in 2025 with $1.02B revenue and $53.6M net income, though recent quarters show earnings misses. Valuation ratios remain elevated with P/E of 46.52 and P/S of 2.1, while analyst consensus targets $39.50 with mixed sentiment.
The stock faces near-term pressure from technical weakness and earnings volatility, but long-term potential exists through AI-driven lending expansion and new auto/HELOC partnerships. Key risks include credit market sensitivity, rising debt levels, and competitive fintech landscape. Current price near recent lows presents opportunity for patient investors despite operational cash flow challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →